Caribou Biosciences (CRBU) Enterprise Value (2020 - 2026)
Caribou Biosciences (CRBU) reported Enterprise Value of -$117.6 million for Q1 2026, up 43.58% year-over-year from -$81.9 million in Q1 2025, and up 15.58% on a QoQ basis from -$139.3 million in Q4 2025.
Caribou Biosciences (CRBU) has 7 years of Enterprise Value data on file, last reported at -$117.6 million in Q1 2026.
- Quarterly Enterprise Value rose 43.58% year-over-year to -$117.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$117.6 million (up 43.58% YoY) and the FY2025 annual result came in at -$139.3 million, up 33.5% from the prior year.
- Enterprise Value grew to -$117.6 million in Q1 2026 per CRBU's latest filing, from -$139.3 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$117.6 million in Q1 2026 and bottomed at -$353.7 million in Q1 2022.
- The 5-year median for Enterprise Value is -$247.7 million (2022), against an average of -$245.9 million.
- The widest annual swing landed in 2022, when Enterprise Value sank 738865.22%; it then soared 43.58% in 2026.
- Tracing CRBU's Enterprise Value over 5 years: stood at -$247.7 million in 2022, then slumped by 32.77% to -$328.8 million in 2023, then surged by 36.28% to -$209.5 million in 2024, then surged by 33.5% to -$139.3 million in 2025, then advanced by 15.58% to -$117.6 million in 2026.
- Per Business Quant, the three latest CRBU Enterprise Value figures stand at -$117.6 million (Q1 2026), -$139.3 million (Q4 2025), and -$147.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Caribou Biosciences | 232.46 Mn | 114.84 Mn | - | -117.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -117.63 Mn |
| Dec 31, 2025 | -139.34 Mn |
| Sep 30, 2025 | -147.26 Mn |
| Jun 30, 2025 | -183.95 Mn |
| Mar 31, 2025 | -208.47 Mn |
| Dec 31, 2024 | -209.54 Mn |
| Sep 30, 2024 | -228.18 Mn |
| Jun 30, 2024 | -261.65 Mn |
| Mar 31, 2024 | -293.99 Mn |
| Dec 31, 2023 | -328.83 Mn |
| Sep 30, 2023 | -338.49 Mn |
| Jun 30, 2023 | -259.23 Mn |
| Mar 31, 2023 | -228.54 Mn |
| Dec 31, 2022 | -247.66 Mn |
| Sep 30, 2022 | -293.37 Mn |
| Jun 30, 2022 | -339.92 Mn |
| Mar 31, 2022 | -353.73 Mn |
| Dec 31, 2021 | -375.83 Mn |
| Sep 30, 2021 | -435.31 Mn |
| Jun 30, 2021 | -46,000.00 |
| Mar 31, 2021 | -145.92 Mn |
| Dec 31, 2020 | -15.95 Mn |
| Sep 30, 2020 | -24.55 Mn |
| Jun 30, 2020 | -33.13 Mn |